BorcherdingBG, KeysorCS, RapoportJL, EliaJ, AmassJ: Motor/vocal tics and compulsive behaviors on stimulant drugs: Is there a common vulnerability?. Psychiatry Res, 33:83–94, 1990.
2.
BussingR, FernandezM, HarwoodM, WeiH, GarvanCW, EybergSM, SwansonJM: Parent and teacher SNAP-IV ratings of attention deficit hyperactivity disorder symptoms: Psychometric properties and normative ratings from a school district sample. Assessment, 15:317–328, 2008.
3.
CarlsonGA, KellyKL: Stimulant rebound: How common is it and what does it mean?. J Child Adolesc Psychopharmacol, 13:137–142, 2003.
4.
CruickshankCC, DyerKR: A review of the clinical pharmacology of methamphetamine. Addiction, 104:1085–1099, 2009.
5.
EvansAH, KatzenschlagerR, PaviourD, O'SullivanJD, AppelS, LawrenceAD, LeesAJ: Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome. Mov Disord, 19:397–405, 2004.
6.
FasanoA, PetrovicI: Insights into pathophysiology of punding reveal possible treatment strategies. Mol Psychiatry, 15:560–573, 2010.
PerugiG, VannucchiG, BedaniF, FavarettoE: Use of stimulants in bipolar disorder. Curr Psychiatry Rep, 19:7, 2017.
11.
PondalM, MarrasC, MiyasakiJ, MoroE, ArmstrongMJ, StrafellaAP, ShahBB, FoxS, PrashanthLK, PhielippN, LangAE: Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic. J Neurol Neurosurg Psychiatry, 84:130–135, 2013.
12.
PostRM, KopandaRT: Cocaine, kindling, and psychosis. Am J Psychiatry, 133:627–634, 1976.
13.
SwansonJM, SchuckS, PorterMM, CarlsonC, HartmanCA, SergeantJA, ClevengerW, WasdellM, McClearyR, LakesK, WigalT: Categorical and dimensional definitions and evaluations of symptoms of ADHD: History of the SNAP and the SWAN rating scales. Int J Educ Psychol Assess, 10:51–70, 2012.
14.
ViktorinA, RydénE, ThaseME, ChangZ, LundholmC, D'OnofrioBM, AlmqvistC, MagnussonPK, LichtensteinP, LarssonH, LandénM: The risk of treatment-emergent mania with methylphenidate in bipolar disorder. Am J Psychiatry, 174:341–348, 2017.
